Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method

Journal of Separation Science

Volumn 31, Issue 4, 2008, Pages 667-676

  Ferreirós, Nerea ^a   Iriarte, Gorka ^a   Alonso, Rosa María ^a   Jiménez, Rosa María ^a   Ortíz, Eduardo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

ARA II; Biovalidation; HPLC DAD; Human urine; SPE

Indexed keywords

CARDIOVASCULAR SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOTODIODES; SEPARATION;

ANTAGONIST DRUG; PHOTODIODE ARRAY DETECTION;

DRUG PRODUCTS;

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; EPROSARTAN; IRBESARTAN; TELMISARTAN; VALSARTAN;

ACCURACY; ANALYTICAL ERROR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ELIMINATION; DRUG EXCRETION; DRUG URINE LEVEL; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; URINALYSIS; VALIDATION PROCESS;

ACRYLATES; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; SOLID PHASE EXTRACTION; TETRAZOLES; THIOPHENES; VALINE;

EID: 41049106938     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200700442     Document Type: Article

References (30)

1. Bauer, J. H., Reams, G. P., Arch. Intern. Med. 1995, 155, 1361-1368.
2. Sica, D. A., Gehr, T. W. B., Ghosh, S., Clinical Pharmacokinetics 2005, 44, 797-814.
3. Plosker, G. L., Foster, R. H., Drugs 2000, 60, 177-201.
4. Sharpe, M., Jarvis, B., Goa, K. L., Drugs 2001, 61, 1501-1529.
5. Croom, K. F., Curran, M. P., Goa, K. L., Perry, C. M., Drugs 2004, 62, 999-1028.
6. Markham, A., Goa, K. L., Drugs 1997, 54, 299-311.
7. Hillaert, S., Van den Bossche, W., J. Chromatogr. A 2002, 979, 323-333.
8. Hillaert, S., Van den Bossche, W., J. Pharm. Biomed. Anal. 2003, 31, 329-339.
9. Hillaert, S., De Beer, T. R. M., De Beer, J. O., Van den Bossche, W., J. Chromatogr. A 2003, 984, 135-146.
10. Gonzalez, L., Alonso, R. M., Jimenez, R. M., Chromatographia 2000, 52, 735-740.
11. Cagigal, E., Gonzalez, L., Alonso, R. M., Jimenez, R. M., Talanta 2001, 54, 1121-1133.
12. Gonzalez, L., Lopez, J. A., Alonso, R. M., Jimenez, R. M., J. Chromatogr. A 2002, 949, 49-60.
13. Torrealday, N., Gonzalez, L., Alonso, R. M., Jimenez, R. M., Ortiz Lastra, E., J. Pharm. Biomed. Anal. 2003, 32, 847-857.
14. Lundberg, D. E., Person, R. C., Knox, S., Cyronak, M. J., J. Chromatogr. B 1998, 707, 328-333.
15. Furtek, C. I., Lo, M. W., J. Chromatogr. 1992, 573, 295-301.
16. Lee, J. W., Naidong, W., Johnson, T., Dzerk, A., Miyabayashi, T., Motohashi, M., J. Chromatogr. B 1995, 670, 287-298.
17. Miyabayashi, T., Okuda, T., Motohashi, M., Izawa, K., Yashiki, T., J. Chromatogr. B 1996, 677, 123-132.
18. Farthing, D., Sica, D., Fakhry, L, Pedro, A., Gehr, T. W. B., J. Chromatogr. B 1997, 704, 374-378.
19. Ritter, M. A., Furtek, C. I., Lo, M. W., J. Pharm. Biomed. Anal. 1997, 15, 1021-1029.
20. Chang, S. Y., Whigan, D. B., Vachharajani, N. N., Patel, R., J. Chromatogr. B 1997, 702, 149-155.
21. Maurer, H. H., Kraemer, T., Arlt, J. W., Therap. Drug Monitor. 1998, 20, 706-713.
22. Soldner, A., Spahn-Langguth, H., Mutschler, E., J. Pharm. Biomed. Anal. 1998, 16, 863-873.
23. Stenhoff, H., Lagerstrom, P. O., Andersen, C., J. Chromatogr. B 1999, 731, 411-417.
24. Polinko, M., Riffel, K., Song, H., Lo, M. W., J. Pharm. Biomed. Anal. 2003, 33, 73-84.
25. Nie, J., Zhang, M., Fan, Y., Wen, Y., Xiang, B., Feng, Y. O., J. Chromatogr. B 2005, 828, 62-69.
26. Zhang, M., Wei, F., Zhang, Y. F., Nie, J., Feng, Y. O., J. Chromatogr. A 2006, 1102, 294-301.
27. Ferreirós, N., Iriarte, G., Alonso, R. M., Jiménez, R. M., Talanta 2007, 73, 748-756.
28. Ferreirós, N., Iriarte, G., Alonso, R. M., Jiménez, R. M., Ortiz, E., J. Chromatogr. A 2006, 1119, 309-314.
29. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, CDER, Rockville, USA, May 2001.
30. Kristoffersen, L., Øiestad, E. L., Opdal, M. S., Krogh, M., Lundanes, E., Christophersen, A. S., J. Chromatogr. B 2007, 850, 147-60.